BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 63 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $592,301 | +96209.1% | 15,129 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $615 | -2.8% | 15,129 | 0.0% | 0.02% | -10.0% |
| Q1 2023 | $633 | -3.9% | 15,129 | 0.0% | 0.02% | -9.1% |
| Q4 2022 | $659 | -99.9% | 15,129 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $587,000 | +9.1% | 15,129 | +19.2% | 0.02% | +15.8% |
| Q2 2022 | $538,000 | -6.9% | 12,695 | 0.0% | 0.02% | +5.6% |
| Q1 2022 | $578,000 | +26.2% | 12,695 | +34.3% | 0.02% | +28.6% |
| Q4 2021 | $458,000 | +1.8% | 9,450 | 0.0% | 0.01% | -6.7% |
| Q3 2021 | $450,000 | -1.7% | 9,450 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $458,000 | +4.8% | 9,450 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $437,000 | -2.9% | 9,450 | 0.0% | 0.02% | -11.8% |
| Q4 2020 | $450,000 | +53.1% | 9,450 | +38.0% | 0.02% | +30.8% |
| Q3 2020 | $294,000 | +10.1% | 6,850 | +4.6% | 0.01% | 0.0% |
| Q2 2020 | $267,000 | – | 6,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ahrens Investment Partners LLC | 74,825 | $3,561,000 | 1.91% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 40,961 | $1,174,000 | 0.99% |
| Diversified, LLC | 19,077 | $818,000 | 0.70% |
| CORRADO ADVISORS, LLC | 9,645 | $459,000 | 0.35% |
| Rikoon Group, LLC | 16,672 | $793,000 | 0.22% |
| Eudaimonia Partners, LLC | 8,240 | $392,000 | 0.09% |
| Arete Wealth Advisors, LLC | 10,658 | $507,000 | 0.07% |
| SOA Wealth Advisors, LLC. | 4,900 | $242,000 | 0.07% |
| Financial Advantage, Inc. | 833 | $39,000 | 0.04% |
| Jacobi Capital Management LLC | 4,184 | $199,000 | 0.03% |